Hamill John 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013
Insider Transaction Report
Form 4
Hamill John
SVP, CFO
Transactions
- Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 totalExercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying)
Holdings
- 103,613
Common Stock
Footnotes (1)
- [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.